September 24, 2024
Minaris Regenerative Medicine Announces Agreement to be Acquired by Altaris (English)
Yokohama, Japan, Munich, Germany, and Allendale, New Jersey, USA. September 24, 2024. Minaris Regenerative Medicine (“Minaris”), a leading cell therapy contract development and manufacturing organization, is pleased to announce that its parent company, Resonac Corporation (“Resonac”), has entered into a definitive agreement to sell Minaris to a fund managed by Altaris, LLC (collectively with its ...
